Kilincalp S, Deveci M, Basar O, Ekiz F, Coban S, Yuksel O

Idioma: Ingles.
Referencias bibliográficas: 8
Paginas: 728-730
Archivo PDF: 63.44 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatology 2005; 43: 901-10.

2. Berdel WE, Bausert WR, Weltzien HU, Modotell ML, Widmann KH, Munder PG. The influence of alkyl-lysophospholipids and lysophospholipid activated macrophages on the development of metastasis of 3-Lewis lung carcinoma. Eur J Cancer 1980; 16: 1199-204.

3. Finkelstein JB. Sharks do get cancer: few surprises in cartilage research. J Natl Cancer Inst 2005; 97: 1562-3.

4. Deniau AL, Mosset P, Pédrono F, Mitre R, Le Bot D, Legrand AB. Multiple beneficial health effects of natural alkylglycerols from shark liver oil. Mar Drugs 2010; 8: 2175-84.

5. Davidson BC, Rottanburg D, Prinz W, Cliff G. The influence of shark liver oils on normal and transformed mammalian cells in culture. In Vivo 2007; 21: 333-7.

6. Dosay-Akbulut M. The determination of the specific characteristics on the immunosurveilance against to cancer formation in elasmobranches. Int J Cancer Res 2006; 2: 119-23.

7. Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995; 25: 1492.

8. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary suplements. Br J Clin Pharmacol 2008; 66: 758-66.